Kuri P, Goswami P
Sci Rep. 2024; 14(1):21464.
PMID: 39271700
PMC: 11399443.
DOI: 10.1038/s41598-024-69896-1.
Zheng X, Jin G
Front Pediatr. 2024; 12:1414177.
PMID: 39022216
PMC: 11251920.
DOI: 10.3389/fped.2024.1414177.
Asensio-Cob D, Rodriguez J, Luque D
Viruses. 2023; 15(8).
PMID: 37632092
PMC: 10458742.
DOI: 10.3390/v15081750.
Shoja Z, Jalilvand S, Latifi T, Roohvand F
Arch Virol. 2022; 167(4):1013-1023.
PMID: 35292854
PMC: 8923333.
DOI: 10.1007/s00705-022-05407-9.
Wang Y, Li J, Liu P, Zhu F
Hum Vaccin Immunother. 2020; 17(3):880-896.
PMID: 32966134
PMC: 7993146.
DOI: 10.1080/21645515.2020.1801071.
Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
Malm M, Heinimaki S, Vesikari T, Blazevic V
Clin Exp Immunol. 2017; 189(3):331-341.
PMID: 28407442
PMC: 5543502.
DOI: 10.1111/cei.12977.
Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles.
Malm M, Tamminen K, Lappalainen S, Vesikari T, Blazevic V
J Immunol Res. 2016; 2016:9171632.
PMID: 27689099
PMC: 5027051.
DOI: 10.1155/2016/9171632.
Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.
Blazevic V, Malm M, Arinobu D, Lappalainen S, Vesikari T
Hum Vaccin Immunother. 2015; 12(3):740-8.
PMID: 26467630
PMC: 4964741.
DOI: 10.1080/21645515.2015.1099772.
Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S, Pastor A, Tamminen K, Lopez-Guerrero V, Esquivel-Guadarrama F, Palomares L
Hum Vaccin Immunother. 2014; 10(7):2039-47.
PMID: 25424814
PMC: 4186038.
DOI: 10.4161/hv.28858.
Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
Lappalainen S, Tamminen K, Vesikari T, Blazevic V
Hum Vaccin Immunother. 2013; 9(9):1991-2001.
PMID: 23777748
PMC: 3906367.
DOI: 10.4161/hv.25249.
A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein.
Kavanagh O, Zeng X, Ramani S, Mukhopadhya I, Crawford S, Kang G
J Virol Methods. 2012; 189(1):228-31.
PMID: 23183143
PMC: 3617367.
DOI: 10.1016/j.jviromet.2012.11.003.
Recombinant outer capsid glycoprotein (VP7) of rotavirus expressed in insect cells induces neutralizing antibodies in rabbits.
Khodabandehloo M, Shahrabadi M, Keyvani H, Bambai B, Sadigh Z
Iran J Public Health. 2012; 41(5):73-84.
PMID: 23113180
PMC: 3468985.
Production of a recombinant major inner capsid protein for serological detection of epizootic hemorrhagic disease virus.
Luo L, Sabara M
Clin Diagn Lab Immunol. 2005; 12(8):904-9.
PMID: 16085906
PMC: 1182188.
DOI: 10.1128/CDLI.12.8.904-909.2005.
Silencing the morphogenesis of rotavirus.
Lopez T, Camacho M, Zayas M, Najera R, Sanchez R, Arias C
J Virol. 2004; 79(1):184-92.
PMID: 15596814
PMC: 538724.
DOI: 10.1128/JVI.79.1.184-192.2005.
Structural polymorphism of the major capsid protein of rotavirus.
Lepault J, Petitpas I, Erk I, Navaza J, Bigot D, Dona M
EMBO J. 2001; 20(7):1498-507.
PMID: 11285214
PMC: 145494.
DOI: 10.1093/emboj/20.7.1498.
A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells.
Zhang M, Zeng C, Morris A, Estes M
J Virol. 2000; 74(24):11663-70.
PMID: 11090165
PMC: 112448.
DOI: 10.1128/jvi.74.24.11663-11670.2000.
Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.
Crawford S, Estes M, Ciarlet M, Barone C, ONeal C, Cohen J
J Virol. 1999; 73(6):4813-22.
PMID: 10233942
PMC: 112524.
DOI: 10.1128/JVI.73.6.4813-4822.1999.
Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.
Ciarlet M, Crawford S, Barone C, Ramig R, Estes M, Conner M
J Virol. 1998; 72(11):9233-46.
PMID: 9765471
PMC: 110343.
DOI: 10.1128/JVI.72.11.9233-9246.1998.
Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence.
Zhang M, Zeng C, Dong Y, Ball J, Saif L, Morris A
J Virol. 1998; 72(5):3666-72.
PMID: 9557647
PMC: 109587.
DOI: 10.1128/JVI.72.5.3666-3672.1998.
Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines.
Fernandez F, Conner M, Hodgins D, Parwani A, Nielsen P, Crawford S
Vaccine. 1998; 16(5):507-16.
PMID: 9491505
PMC: 7131086.
DOI: 10.1016/s0264-410x(97)80004-7.